Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: a population-based study
Brent SE, McGee J, Vicus D, Kim R, Eisen A, Wilton AS, Gien LT. Int J Gynaecol Obstet. 2024; Jan 29 [Epub ahead of print].